Showing results (71-80 of 74) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Frontiers in Oncology|July 26, 2021
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter StudyJason C Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2022
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinomaChun-Wei Lu, Jong-Hwei Su Pang, Yu-Shien Ko, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2024
Class I HLA Alleles Are Associated With an Increased Risk of Osimertinib-Induced HypersensitivityChun-Bing Chen, Chuang-Wei Wang, Chun-Wei Lu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 StudyNatasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, et al.Pageof 8